Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection-Reference-Cited by-同舟云学术

Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection

Published:2023-02-16 Issue:2 Volume:67 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Kunkel M.¹,Doyle-Eisele M.²,Kuehl P.²,Rotermund K.³,Hittinger M.³,Ufer S.⁴,Reed M.⁵,Grant M.⁶,Hofmann T.⁶^ORCID

Affiliation:

1. MarkAllen Consulting LLC, Lawrenceville, New Jersey, USA

2. Lovelace Biomedical, Albuquerque, New Mexico, USA

3. PharmBioTec Research and Development GmbH, Saarbrücken, Germany

4. Swabian Tech LLC, Raleigh, North Carolina, USA

5. COELUS LLC, Albuquerque, New Mexico, USA

6. MannKind Corporation, Danbury, Connecticut, USA

Abstract

Pulmonary nontuberculous mycobacteria (NTM) infection is recognized as a major global health concern due to its rising prevalence worldwide. As an opportunistic pathogen with increasing antibiotics resistance, prolonged systemic dosing with multiple antibiotics remains the primary treatment paradigm.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.01144-22

Reference27 articles.

1. Clofazimine susceptibility testing of Mycobacterium avium complex and Mycobacterium abscessus: a meta-analysis study

2. Clofazimine for treatment of multidrug-resistant non-tuberculous mycobacteria

3. Clofazimine: current status and future prospects

4. Systematic review of clofazimine for the treatment of drug-resistant tuberculosis [Review article]

5. Novartis Pharmaceuticals Corporation. 2016. LAMPRENE (clofazimine) capsules for oral use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019500s013lbl.pdf.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growing from common ground: nontuberculous mycobacteria and bronchiectasis;European Respiratory Review;2024-07

2. Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products;Current Topics in Medicinal Chemistry;2024-06

3. Triple-Antibiotic Combination Exerts Effective Activity against Mycobacterium avium subsp. hominissuis Biofilm and Airway Infection in an In Vivo Murine Model;Antibiotics;2024-05-22

4. Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis;Journal of Controlled Release;2024-05

5. Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine;Infection;2024-02-08